Release Date: 01/06/20 10:55 Summary: Creso Pharma Receives Firm Commitments to Raise A$2.137M Price Sensitive: Yes Download Document 105.15KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%